Lehigh Center for Clinical Research

Founded in 1999, GENEWIZ Inc. is a global contract research organization providing deoxyribonucleic acid (DNA) services. Based in South Plainfield, N.J., the firm offers a range of services, such as DNA sequencing, gene synthesis, molecular biology and genomic services. Its Good Laboratory Practice (GLP) services include double strand sequence confirmation, primer walking, nucleic acid extraction and reverse transcription polymerase chain reaction and sequencing. GENEWIZ Inc. caters to numerous market segments, including academic, pharmaceutical, clinical, biotechnology and government institutions.

Saladax Biomedical, Inc, based in Bethlehem, PA, is revolutionizing psychiatry and oncology with rapid therapeutic drug monitoring assays. Their cutting-edge technology delivers rapid blood levels of commonly prescribed drugs, empowering healthcare providers to optimize patient care and make informed decisions about therapeutic interventions. As a pioneer in the field, Saladax is dedicated to enhancing patient outcomes by developing, manufacturing, and marketing innovative TDM assays for use in clinical laboratories or at point of care. Their assays play a pivotal role in providing real-time insights that minimize risks of suboptimal drug dosing or toxicities, ultimately transforming day-to-day clinical decisions for patients in the United States, Canada, Europe, and the Middle East. Generated from the website

ICON Clinical Research, based in North Wales, PA, is a premier Contract Research Organisation that offers a comprehensive range of clinical consulting and commercial services across multiple sectors, including biotech, pharmaceuticals, and medical devices. With a focus on innovative and patient-centric solutions, ICON is dedicated to advancing drug development through strategic partnerships and cutting-edge technologies. The company specializes in various therapeutic areas, providing tailored support for the unique needs of clients, including early clinical solutions, cardiac safety, and market access expertise. ICON is committed to enhancing research and development return on investment while actively contributing to community well-being through its ICON Cares program, which emphasizes sustainability and social responsibility. Generated from the website